Published in J Clin Virol on April 01, 2003
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis (2010) 1.85
Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis (2013) 1.54
A case of herpes zoster with abducens palsy. J Korean Med Sci (2007) 1.16
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol (2006) 1.15
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ (2012) 1.05
Varicella-zoster virus reactivation from multiple ganglia: a case report. J Med Case Rep (2009) 0.98
Herpes zoster - associated erythema multiforme. J Dermatol Case Rep (2009) 0.92
Managing ophthalmic herpes zoster in primary care. BMJ (2005) 0.92
Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health (2009) 0.91
Herpes zoster ophthalmicus associated with abducens palsy. J Neurosci Rural Pract (2014) 0.91
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. Antimicrob Agents Chemother (2005) 0.89
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res (2013) 0.89
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine. Int J Biomed Sci (2009) 0.81
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Hum Vaccin Immunother (2015) 0.78
Herpes zoster guidelines of the German Dermatological Society. J Clin Virol (2003) 0.78
A Supraglottic Pseudotumor in an Immunocompromised Patient with Nephrotic Syndrome, Herpes Zoster, and a Cytomegalovirus Infection. Clin Med Insights Case Rep (2016) 0.78
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med (2009) 0.77
Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health (2015) 0.76
Topical glycopirrolate for the management of hyperhidrosis in herpetic neuralgia. Yonsei Med J (2009) 0.75
Mandibular osteonecrosis following herpes zoster infection in the mandibular branch of the trigeminal nerve: a case report and literature review. J Korean Assoc Oral Maxillofac Surg (2015) 0.75
Lower Back Pain with Sciatic Disorder Following L5 Dermatome Caused by Herpes Zoster Infection. Orthop Rev (Pavia) (2015) 0.75
Atypical Presentation of Herpes Zoster Duplex Bilateralis in a Renal Transplanted Patient. Healthcare (Basel) (2013) 0.75
Bilateral herpes zoster in a patient with end-stage kidney disease. Int Med Case Rep J (2017) 0.75
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection (1991) 3.29
Treatment of SARS with human interferons. Lancet (2003) 3.10
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Molecular basis for biosynthesis and accumulation of polyhydroxyalkanoic acids in bacteria. FEMS Microbiol Rev (1992) 2.18
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol (2000) 2.12
Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant (2010) 2.10
[Evaluation of the Freiburg monosyllabic speech test in background noise]. HNO (2013) 2.04
Hemisensory impairment in patients with complex regional pain syndrome. Pain (1999) 1.90
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (2003) 1.88
Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection (2003) 1.78
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. Cell Death Dis (2011) 1.51
Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival. AIDS (1998) 1.51
[Modified Heidelberg Retinal Tomograph HRT. Initial results of in vivo presentation of corneal structures]. Ophthalmologe (2002) 1.51
Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion. Plast Reconstr Surg (1999) 1.46
Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43
Phenotypic variability in rippling muscle disease. Neurology (1999) 1.43
Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology (1998) 1.43
[Estimation of accident risk in obstructive sleep apnea syndrome (OSAS) by driving simulation]. Pneumologie (2002) 1.40
[Acoustic-mechanical trauma during cochleostomy: animal experimental studies]. HNO (2011) 1.40
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39
Changes of cortical motor area size during immobilization. Electroencephalogr Clin Neurophysiol (1995) 1.38
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
[Tongue fixation system for therapy of sleeping disorders. A feasibility study]. HNO (2010) 1.38
Tl(2)CO(3) at 3.56 GPa. Acta Crystallogr C (2008) 1.38
Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol (2010) 1.36
Laboratory diagnosis of herpes zoster. J Clin Virol (1999) 1.32
Shifts in cortical representations predict human discrimination improvement. Proc Natl Acad Sci U S A (2001) 1.30
An influenza A H1N1 virus revival - pandemic H1N1/09 virus. Infection (2009) 1.30
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol (2000) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm (Vienna) (1997) 1.22
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J Virol Methods (1996) 1.20
Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet (2001) 1.20
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg (1996) 1.19
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
[The role of episcleral venous pressure in the development of secondary glaucomas]. Klin Monbl Augenheilkd (1988) 1.17
The congenital varicella syndrome. J Perinatol (2000) 1.17
Activation and activation-driven death of human gamma/delta T cells. Immunol Rev (1991) 1.16
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol (2006) 1.15
Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods (1995) 1.14
New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res (1999) 1.14
Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol (2006) 1.14
Influenza vaccination compliance among health care workers in a German university hospital. Infection (2008) 1.13
Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J Med Virol (2003) 1.12
[Muscle pedunculated scleral flaps. A microsurgical modification to improve prosthesis motility]. Ophthalmologe (2003) 1.11
Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod (2002) 1.11
Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect (2004) 1.11
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol (1994) 1.10
Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. J Neurol Sci (1998) 1.10
FasL:Fas ratio--a prognostic factor in breast carcinomas. Cancer Res (2000) 1.10
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol (2000) 1.09
Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol (2001) 1.09
Stability and inactivation of SARS coronavirus. Med Microbiol Immunol (2005) 1.09
Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain (2001) 1.09
The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol (2001) 1.08
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections. Med Microbiol Immunol (2006) 1.07
Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010. Euro Surveill (2014) 1.07
Viral zoonoses - a threat under control? Intervirology (2003) 1.07
Minimal cross-infection risk through Icare rebound tonometer probes: a useful tool for IOP-screenings in developing countries. Eye (Lond) (2009) 1.07
Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay. J Clin Microbiol (1997) 1.06
Virological diagnosis of herpes simplex encephalitis. J Clin Virol (2000) 1.06
Antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disorders. J Ethnopharmacol (2005) 1.05
Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol (2001) 1.05
[Virologic diagnosis of herpes zoster]. Hautarzt (1999) 1.05
Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology (1996) 1.05
Neurofibromatosis 2 in the pediatric age group. Neurosurgery (1993) 1.05
Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient. Infect Dis Obstet Gynecol (2010) 1.04
Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol (1996) 1.04
Laboratory diagnosis of norovirus: which method is the best? Intervirology (2003) 1.04
Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology (2002) 1.04
Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol (1994) 1.03
Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett (1999) 1.03
Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion? Curr Drug Targets Infect Disord (2003) 1.03
The Lester-Jones tube: a 15-year follow-up. Graefes Arch Clin Exp Ophthalmol (1985) 1.03
Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (2002) 1.02
Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer (1996) 1.02
Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anticancer Drugs (1996) 1.02
Analysis of 107 breast lesions with automated 3D ultrasound and comparison with mammography and manual ultrasound. Eur J Radiol (2008) 1.01
Polyneuropathy associated with chronic hypoxaemia: prevalence in patients with chronic obstructive pulmonary disease. J Neurol (1990) 1.00
[How can artificial eye motility be improved? The influence of fornix configuration and tissue thickness in front of hydroxyapatite-silicon implants in 66 patients]. Ophthalmologe (2003) 1.00
T cell receptor gamma delta repertoire in HIV-1-infected individuals. Eur J Immunol (1994) 1.00
High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology (2000) 1.00
Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. J Med Virol (2007) 1.00
Comparison of different methods for the detection of rubella-specific IgM antibodies. J Med Virol (1981) 1.00
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ (2006) 1.00
[Pathogenesis of unilateral dilated episcleral vessels and increase in intraocular pressure]. Klin Monbl Augenheilkd (1987) 0.99
Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Methods (2004) 0.99
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals. AIDS (2001) 0.99
Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta (2007) 0.99
Testing for Chlamydia trachomatis in urine. Lancet (1997) 0.99
Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells. Eur J Immunol (1996) 0.99
Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods (1993) 0.99
Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol (2001) 0.98
Rapid method to detect rubella immunoglobulin M and immunoglobulin A antibodies. J Clin Microbiol (1975) 0.98
Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect (2008) 0.98
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res (2010) 0.98